Preventing Smoking Relapse After Total Joint Replacement Surgery
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Smoking Cessation, Smoking Cessation |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 100 |
| Updated: | 1/9/2019 |
| Start Date: | March 2019 |
| End Date: | October 2020 |
| Contact: | Yaa Haber |
| Email: | yaa.haber@nyumc.org |
| Phone: | 646 501 2636 |
Hospitalization for elective knee or hip replacement surgery presents an outstanding
opportunity to motivate people to quit smoking, because it provides an opportunity to
encourage patients to remain smoke-free as they proactively quit to optimize their surgery
outcomes. This study will conduct a comparative effectiveness trial of patients who quit
smoking pre-operatively, comparing the current standard of care with a novel comprehensive
relapse prevention intervention guided by Marlatt's Relapse Prevention Model.
opportunity to motivate people to quit smoking, because it provides an opportunity to
encourage patients to remain smoke-free as they proactively quit to optimize their surgery
outcomes. This study will conduct a comparative effectiveness trial of patients who quit
smoking pre-operatively, comparing the current standard of care with a novel comprehensive
relapse prevention intervention guided by Marlatt's Relapse Prevention Model.
The specific aims of this study are to evaluate the effectiveness and cost-effectiveness of
the relapse prevention intervention and will: 1) compare the effectiveness of standard
post-operative cessation treatment with a comprehensive relapse prevention intervention on
smoking cessation outcomes; 2) conduct a comparative economic analysis to assess the value of
the relapse prevention intervention for patients and the healthcare system; and 3) explore
the impact of the interventions on surgical complications and readmissions.
the relapse prevention intervention and will: 1) compare the effectiveness of standard
post-operative cessation treatment with a comprehensive relapse prevention intervention on
smoking cessation outcomes; 2) conduct a comparative economic analysis to assess the value of
the relapse prevention intervention for patients and the healthcare system; and 3) explore
the impact of the interventions on surgical complications and readmissions.
Inclusion Criteria:
Patient Participants
- Received preoperative smoking cessation counseling through Orthopedic Surgery Quit
Smoking Program
- Undergoing elective knee or hip arthroplasty surgery
- Have not smoked any cigarettes in the week prior to admission and carbon monoxide 4
ppm46,47
- Have a cell phone (for text messaging)
- Provide informed consent in English
Caregiver participants:
- Age ≥ 18 years
- Be a caregiver of the patient participant
- Provide informed consent in English
Exclusion Criteria:
- Patients will be excluded if they used smokeless tobacco or an electronic cigarette in
the last 30 days.
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Scott Sherman, MD
Phone: 646-501-2636
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
